The Safety and Effectiveness of Bevacizumab in the Treatment of Nonsquamous Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: Bevacizumab was currently available for nonsquamous non-small-cell lung cancer (NSqNSCLC) patients and has been studied in several randomized controlled trials (RCTs) for treatment of these patients. This meta-analysis summarizes the most up-to-date evidences regarding the effects and adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yue, He, Mei, Li, Rui, Peng, Yuan, Li, Feng, Li, Shengqian, Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440089/
https://www.ncbi.nlm.nih.gov/pubmed/34532503
http://dx.doi.org/10.1155/2021/5537899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440089/
https://www.ncbi.nlm.nih.gov/pubmed/34532503
http://dx.doi.org/10.1155/2021/5537899

Ejemplares similares